0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Radiopaque Contrast Agents Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-11T14228
Home | Market Reports | Health| Medical Devices & Equipment
Global Radiopaque Contrast Agents Market Research Report 2023
BUY CHAPTERS

Global Radiopaque Contrast Agents Market Research Report 2025

Code: QYRE-Auto-11T14228
Report
May 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Radiopaque Contrast Agents Market

The global market for Radiopaque Contrast Agents was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Radiopaque Contrast Agents is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Radiopaque Contrast Agents is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Radiopaque Contrast Agents in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Radiopaque Contrast Agents include Bracco, GE Healthcare, Bayer, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Radiopaque Contrast Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopaque Contrast Agents.
The Radiopaque Contrast Agents market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiopaque Contrast Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiopaque Contrast Agents companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Radiopaque Contrast Agents Market Report

Report Metric Details
Report Name Radiopaque Contrast Agents Market
Segment by Type
  • X-ray
  • CT
Segment by Application
  • Hospitals
  • Clinics
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bracco, GE Healthcare, Bayer, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Radiopaque Contrast Agents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Radiopaque Contrast Agents Market report?

Ans: The main players in the Radiopaque Contrast Agents Market are Bracco, GE Healthcare, Bayer, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma

What are the Application segmentation covered in the Radiopaque Contrast Agents Market report?

Ans: The Applications covered in the Radiopaque Contrast Agents Market report are Hospitals, Clinics

What are the Type segmentation covered in the Radiopaque Contrast Agents Market report?

Ans: The Types covered in the Radiopaque Contrast Agents Market report are X-ray, CT

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiopaque Contrast Agents Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 X-ray
1.2.3 CT
1.3 Market by Application
1.3.1 Global Radiopaque Contrast Agents Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiopaque Contrast Agents Market Perspective (2020-2031)
2.2 Global Radiopaque Contrast Agents Growth Trends by Region
2.2.1 Global Radiopaque Contrast Agents Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Radiopaque Contrast Agents Historic Market Size by Region (2020-2025)
2.2.3 Radiopaque Contrast Agents Forecasted Market Size by Region (2026-2031)
2.3 Radiopaque Contrast Agents Market Dynamics
2.3.1 Radiopaque Contrast Agents Industry Trends
2.3.2 Radiopaque Contrast Agents Market Drivers
2.3.3 Radiopaque Contrast Agents Market Challenges
2.3.4 Radiopaque Contrast Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiopaque Contrast Agents Players by Revenue
3.1.1 Global Top Radiopaque Contrast Agents Players by Revenue (2020-2025)
3.1.2 Global Radiopaque Contrast Agents Revenue Market Share by Players (2020-2025)
3.2 Global Radiopaque Contrast Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Radiopaque Contrast Agents Revenue
3.4 Global Radiopaque Contrast Agents Market Concentration Ratio
3.4.1 Global Radiopaque Contrast Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiopaque Contrast Agents Revenue in 2024
3.5 Global Key Players of Radiopaque Contrast Agents Head office and Area Served
3.6 Global Key Players of Radiopaque Contrast Agents, Product and Application
3.7 Global Key Players of Radiopaque Contrast Agents, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiopaque Contrast Agents Breakdown Data by Type
4.1 Global Radiopaque Contrast Agents Historic Market Size by Type (2020-2025)
4.2 Global Radiopaque Contrast Agents Forecasted Market Size by Type (2026-2031)
5 Radiopaque Contrast Agents Breakdown Data by Application
5.1 Global Radiopaque Contrast Agents Historic Market Size by Application (2020-2025)
5.2 Global Radiopaque Contrast Agents Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Radiopaque Contrast Agents Market Size (2020-2031)
6.2 North America Radiopaque Contrast Agents Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Radiopaque Contrast Agents Market Size by Country (2020-2025)
6.4 North America Radiopaque Contrast Agents Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiopaque Contrast Agents Market Size (2020-2031)
7.2 Europe Radiopaque Contrast Agents Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Radiopaque Contrast Agents Market Size by Country (2020-2025)
7.4 Europe Radiopaque Contrast Agents Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiopaque Contrast Agents Market Size (2020-2031)
8.2 Asia-Pacific Radiopaque Contrast Agents Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Radiopaque Contrast Agents Market Size by Region (2020-2025)
8.4 Asia-Pacific Radiopaque Contrast Agents Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radiopaque Contrast Agents Market Size (2020-2031)
9.2 Latin America Radiopaque Contrast Agents Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Radiopaque Contrast Agents Market Size by Country (2020-2025)
9.4 Latin America Radiopaque Contrast Agents Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiopaque Contrast Agents Market Size (2020-2031)
10.2 Middle East & Africa Radiopaque Contrast Agents Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Radiopaque Contrast Agents Market Size by Country (2020-2025)
10.4 Middle East & Africa Radiopaque Contrast Agents Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bracco
11.1.1 Bracco Company Details
11.1.2 Bracco Business Overview
11.1.3 Bracco Radiopaque Contrast Agents Introduction
11.1.4 Bracco Revenue in Radiopaque Contrast Agents Business (2020-2025)
11.1.5 Bracco Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Radiopaque Contrast Agents Introduction
11.2.4 GE Healthcare Revenue in Radiopaque Contrast Agents Business (2020-2025)
11.2.5 GE Healthcare Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Radiopaque Contrast Agents Introduction
11.3.4 Bayer Revenue in Radiopaque Contrast Agents Business (2020-2025)
11.3.5 Bayer Recent Development
11.4 Guerbet Group
11.4.1 Guerbet Group Company Details
11.4.2 Guerbet Group Business Overview
11.4.3 Guerbet Group Radiopaque Contrast Agents Introduction
11.4.4 Guerbet Group Revenue in Radiopaque Contrast Agents Business (2020-2025)
11.4.5 Guerbet Group Recent Development
11.5 Hengrui Medicine
11.5.1 Hengrui Medicine Company Details
11.5.2 Hengrui Medicine Business Overview
11.5.3 Hengrui Medicine Radiopaque Contrast Agents Introduction
11.5.4 Hengrui Medicine Revenue in Radiopaque Contrast Agents Business (2020-2025)
11.5.5 Hengrui Medicine Recent Development
11.6 Lantheus
11.6.1 Lantheus Company Details
11.6.2 Lantheus Business Overview
11.6.3 Lantheus Radiopaque Contrast Agents Introduction
11.6.4 Lantheus Revenue in Radiopaque Contrast Agents Business (2020-2025)
11.6.5 Lantheus Recent Development
11.7 YRPG
11.7.1 YRPG Company Details
11.7.2 YRPG Business Overview
11.7.3 YRPG Radiopaque Contrast Agents Introduction
11.7.4 YRPG Revenue in Radiopaque Contrast Agents Business (2020-2025)
11.7.5 YRPG Recent Development
11.8 BeiLu Pharma
11.8.1 BeiLu Pharma Company Details
11.8.2 BeiLu Pharma Business Overview
11.8.3 BeiLu Pharma Radiopaque Contrast Agents Introduction
11.8.4 BeiLu Pharma Revenue in Radiopaque Contrast Agents Business (2020-2025)
11.8.5 BeiLu Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Radiopaque Contrast Agents Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of X-ray
 Table 3. Key Players of CT
 Table 4. Global Radiopaque Contrast Agents Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Radiopaque Contrast Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Radiopaque Contrast Agents Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Radiopaque Contrast Agents Market Share by Region (2020-2025)
 Table 8. Global Radiopaque Contrast Agents Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Radiopaque Contrast Agents Market Share by Region (2026-2031)
 Table 10. Radiopaque Contrast Agents Market Trends
 Table 11. Radiopaque Contrast Agents Market Drivers
 Table 12. Radiopaque Contrast Agents Market Challenges
 Table 13. Radiopaque Contrast Agents Market Restraints
 Table 14. Global Radiopaque Contrast Agents Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Radiopaque Contrast Agents Market Share by Players (2020-2025)
 Table 16. Global Top Radiopaque Contrast Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopaque Contrast Agents as of 2024)
 Table 17. Ranking of Global Top Radiopaque Contrast Agents Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Radiopaque Contrast Agents Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Radiopaque Contrast Agents, Headquarters and Area Served
 Table 20. Global Key Players of Radiopaque Contrast Agents, Product and Application
 Table 21. Global Key Players of Radiopaque Contrast Agents, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Radiopaque Contrast Agents Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Radiopaque Contrast Agents Revenue Market Share by Type (2020-2025)
 Table 25. Global Radiopaque Contrast Agents Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Radiopaque Contrast Agents Revenue Market Share by Type (2026-2031)
 Table 27. Global Radiopaque Contrast Agents Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Radiopaque Contrast Agents Revenue Market Share by Application (2020-2025)
 Table 29. Global Radiopaque Contrast Agents Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Radiopaque Contrast Agents Revenue Market Share by Application (2026-2031)
 Table 31. North America Radiopaque Contrast Agents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Radiopaque Contrast Agents Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Radiopaque Contrast Agents Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Radiopaque Contrast Agents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Radiopaque Contrast Agents Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Radiopaque Contrast Agents Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Radiopaque Contrast Agents Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Radiopaque Contrast Agents Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Radiopaque Contrast Agents Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Radiopaque Contrast Agents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Radiopaque Contrast Agents Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Radiopaque Contrast Agents Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Radiopaque Contrast Agents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Radiopaque Contrast Agents Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Radiopaque Contrast Agents Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Bracco Company Details
 Table 47. Bracco Business Overview
 Table 48. Bracco Radiopaque Contrast Agents Product
 Table 49. Bracco Revenue in Radiopaque Contrast Agents Business (2020-2025) & (US$ Million)
 Table 50. Bracco Recent Development
 Table 51. GE Healthcare Company Details
 Table 52. GE Healthcare Business Overview
 Table 53. GE Healthcare Radiopaque Contrast Agents Product
 Table 54. GE Healthcare Revenue in Radiopaque Contrast Agents Business (2020-2025) & (US$ Million)
 Table 55. GE Healthcare Recent Development
 Table 56. Bayer Company Details
 Table 57. Bayer Business Overview
 Table 58. Bayer Radiopaque Contrast Agents Product
 Table 59. Bayer Revenue in Radiopaque Contrast Agents Business (2020-2025) & (US$ Million)
 Table 60. Bayer Recent Development
 Table 61. Guerbet Group Company Details
 Table 62. Guerbet Group Business Overview
 Table 63. Guerbet Group Radiopaque Contrast Agents Product
 Table 64. Guerbet Group Revenue in Radiopaque Contrast Agents Business (2020-2025) & (US$ Million)
 Table 65. Guerbet Group Recent Development
 Table 66. Hengrui Medicine Company Details
 Table 67. Hengrui Medicine Business Overview
 Table 68. Hengrui Medicine Radiopaque Contrast Agents Product
 Table 69. Hengrui Medicine Revenue in Radiopaque Contrast Agents Business (2020-2025) & (US$ Million)
 Table 70. Hengrui Medicine Recent Development
 Table 71. Lantheus Company Details
 Table 72. Lantheus Business Overview
 Table 73. Lantheus Radiopaque Contrast Agents Product
 Table 74. Lantheus Revenue in Radiopaque Contrast Agents Business (2020-2025) & (US$ Million)
 Table 75. Lantheus Recent Development
 Table 76. YRPG Company Details
 Table 77. YRPG Business Overview
 Table 78. YRPG Radiopaque Contrast Agents Product
 Table 79. YRPG Revenue in Radiopaque Contrast Agents Business (2020-2025) & (US$ Million)
 Table 80. YRPG Recent Development
 Table 81. BeiLu Pharma Company Details
 Table 82. BeiLu Pharma Business Overview
 Table 83. BeiLu Pharma Radiopaque Contrast Agents Product
 Table 84. BeiLu Pharma Revenue in Radiopaque Contrast Agents Business (2020-2025) & (US$ Million)
 Table 85. BeiLu Pharma Recent Development
 Table 86. Research Programs/Design for This Report
 Table 87. Key Data Information from Secondary Sources
 Table 88. Key Data Information from Primary Sources
 Table 89. Authors List of This Report


List of Figures
 Figure 1. Radiopaque Contrast Agents Picture
 Figure 2. Global Radiopaque Contrast Agents Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Radiopaque Contrast Agents Market Share by Type: 2024 VS 2031
 Figure 4. X-ray Features
 Figure 5. CT Features
 Figure 6. Global Radiopaque Contrast Agents Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Radiopaque Contrast Agents Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Clinics Case Studies
 Figure 10. Radiopaque Contrast Agents Report Years Considered
 Figure 11. Global Radiopaque Contrast Agents Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Radiopaque Contrast Agents Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Radiopaque Contrast Agents Market Share by Region: 2024 VS 2031
 Figure 14. Global Radiopaque Contrast Agents Market Share by Players in 2024
 Figure 15. Global Top Radiopaque Contrast Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopaque Contrast Agents as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Radiopaque Contrast Agents Revenue in 2024
 Figure 17. North America Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Radiopaque Contrast Agents Market Share by Country (2020-2031)
 Figure 19. United States Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Radiopaque Contrast Agents Market Share by Country (2020-2031)
 Figure 23. Germany Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Radiopaque Contrast Agents Market Share by Region (2020-2031)
 Figure 31. China Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Radiopaque Contrast Agents Market Share by Country (2020-2031)
 Figure 39. Mexico Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Radiopaque Contrast Agents Market Share by Country (2020-2031)
 Figure 43. Turkey Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Radiopaque Contrast Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Bracco Revenue Growth Rate in Radiopaque Contrast Agents Business (2020-2025)
 Figure 47. GE Healthcare Revenue Growth Rate in Radiopaque Contrast Agents Business (2020-2025)
 Figure 48. Bayer Revenue Growth Rate in Radiopaque Contrast Agents Business (2020-2025)
 Figure 49. Guerbet Group Revenue Growth Rate in Radiopaque Contrast Agents Business (2020-2025)
 Figure 50. Hengrui Medicine Revenue Growth Rate in Radiopaque Contrast Agents Business (2020-2025)
 Figure 51. Lantheus Revenue Growth Rate in Radiopaque Contrast Agents Business (2020-2025)
 Figure 52. YRPG Revenue Growth Rate in Radiopaque Contrast Agents Business (2020-2025)
 Figure 53. BeiLu Pharma Revenue Growth Rate in Radiopaque Contrast Agents Business (2020-2025)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart